nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—Crohn's disease	0.755	1	CiPCiCtD
Cytarabine—SLC29A1—Mercaptopurine—Crohn's disease	0.193	0.973	CbGbCtD
Cytarabine—CYP3A4—Prednisone—Crohn's disease	0.00535	0.027	CbGbCtD
Cytarabine—POLD1—mouth—Crohn's disease	0.00259	0.0756	CbGeAlD
Cytarabine—POLB—skin of body—Crohn's disease	0.00176	0.0512	CbGeAlD
Cytarabine—POLD1—skin of body—Crohn's disease	0.00144	0.0418	CbGeAlD
Cytarabine—DCTD—smooth muscle tissue—Crohn's disease	0.00143	0.0418	CbGeAlD
Cytarabine—POLB—lymphoid tissue—Crohn's disease	0.00142	0.0415	CbGeAlD
Cytarabine—DCTD—mammalian vulva—Crohn's disease	0.00129	0.0376	CbGeAlD
Cytarabine—Azacitidine—DNMT3A—Crohn's disease	0.00124	0.381	CrCbGaD
Cytarabine—Decitabine—DNMT3A—Crohn's disease	0.00121	0.372	CrCbGaD
Cytarabine—CDA—mammalian vulva—Crohn's disease	0.00117	0.0342	CbGeAlD
Cytarabine—POLD1—lymphoid tissue—Crohn's disease	0.00116	0.0339	CbGeAlD
Cytarabine—NT5E—epithelium—Crohn's disease	0.00115	0.0336	CbGeAlD
Cytarabine—POLD1—digestive system—Crohn's disease	0.00115	0.0335	CbGeAlD
Cytarabine—DCTD—digestive system—Crohn's disease	0.00113	0.033	CbGeAlD
Cytarabine—NT5E—smooth muscle tissue—Crohn's disease	0.00111	0.0323	CbGeAlD
Cytarabine—NT5E—skin of body—Crohn's disease	0.0011	0.0319	CbGeAlD
Cytarabine—CDA—lymphoid tissue—Crohn's disease	0.00104	0.0304	CbGeAlD
Cytarabine—NT5E—mammalian vulva—Crohn's disease	0.000999	0.0291	CbGeAlD
Cytarabine—POLE—mammalian vulva—Crohn's disease	0.000979	0.0285	CbGeAlD
Cytarabine—NT5E—lymphoid tissue—Crohn's disease	0.000887	0.0258	CbGeAlD
Cytarabine—POLE—lymphoid tissue—Crohn's disease	0.000869	0.0253	CbGeAlD
Cytarabine—POLE—digestive system—Crohn's disease	0.000858	0.025	CbGeAlD
Cytarabine—POLA1—mammalian vulva—Crohn's disease	0.000844	0.0246	CbGeAlD
Cytarabine—POLB—lymph node—Crohn's disease	0.000803	0.0234	CbGeAlD
Cytarabine—POLD1—lymph node—Crohn's disease	0.000656	0.0191	CbGeAlD
Cytarabine—SLC22A2—Organic cation transport—SLC22A5—Crohn's disease	0.000654	0.0741	CbGpPWpGaD
Cytarabine—SLC22A2—Organic cation transport—SLC22A4—Crohn's disease	0.000654	0.0741	CbGpPWpGaD
Cytarabine—DCTD—lymph node—Crohn's disease	0.000647	0.0189	CbGeAlD
Cytarabine—POLD1—Danazol—Prednisone—Crohn's disease	0.000629	0.594	CbGdCrCtD
Cytarabine—SLC22A1—Organic cation transport—SLC22A4—Crohn's disease	0.00061	0.0691	CbGpPWpGaD
Cytarabine—SLC22A1—Organic cation transport—SLC22A5—Crohn's disease	0.00061	0.0691	CbGpPWpGaD
Cytarabine—CDA—lymph node—Crohn's disease	0.000589	0.0172	CbGeAlD
Cytarabine—Glucosamine—IFNG—Crohn's disease	0.00057	0.175	CrCbGaD
Cytarabine—SLC22A2—digestive system—Crohn's disease	0.000551	0.016	CbGeAlD
Cytarabine—SLC29A1—mammalian vulva—Crohn's disease	0.000544	0.0159	CbGeAlD
Cytarabine—DCK—mammalian vulva—Crohn's disease	0.00052	0.0152	CbGeAlD
Cytarabine—NT5E—lymph node—Crohn's disease	0.0005	0.0146	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—TNFSF11—Crohn's disease	0.000499	0.0565	CbGpPWpGaD
Cytarabine—ABCC10—mammalian vulva—Crohn's disease	0.000496	0.0144	CbGeAlD
Cytarabine—POLE—lymph node—Crohn's disease	0.00049	0.0143	CbGeAlD
Cytarabine—SLC29A1—lymphoid tissue—Crohn's disease	0.000483	0.0141	CbGeAlD
Cytarabine—SLC29A1—digestive system—Crohn's disease	0.000477	0.0139	CbGeAlD
Cytarabine—DCK—lymphoid tissue—Crohn's disease	0.000462	0.0135	CbGeAlD
Cytarabine—DCK—digestive system—Crohn's disease	0.000456	0.0133	CbGeAlD
Cytarabine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.000444	0.0503	CbGpPWpGaD
Cytarabine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.000444	0.0503	CbGpPWpGaD
Cytarabine—ABCC10—lymphoid tissue—Crohn's disease	0.00044	0.0128	CbGeAlD
Cytarabine—ABCC10—digestive system—Crohn's disease	0.000435	0.0127	CbGeAlD
Cytarabine—POLA1—lymph node—Crohn's disease	0.000423	0.0123	CbGeAlD
Cytarabine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.000414	0.0469	CbGpPWpGaD
Cytarabine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.000414	0.0469	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—IL3—Crohn's disease	0.000327	0.0371	CbGpPWpGaD
Cytarabine—SLC29A1—lymph node—Crohn's disease	0.000273	0.00795	CbGeAlD
Cytarabine—DCK—lymph node—Crohn's disease	0.000261	0.00759	CbGeAlD
Cytarabine—ABCC10—lymph node—Crohn's disease	0.000248	0.00723	CbGeAlD
Cytarabine—Glucosamine—TNF—Crohn's disease	0.000239	0.0732	CrCbGaD
Cytarabine—DCK—Desoximetasone—Prednisone—Crohn's disease	0.000218	0.206	CbGdCrCtD
Cytarabine—DCK—Diflorasone—Prednisone—Crohn's disease	0.000212	0.2	CbGdCrCtD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000192	0.0217	CbGpPWpGaD
Cytarabine—CYP3A4—digestive system—Crohn's disease	0.000177	0.00517	CbGeAlD
Cytarabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000127	0.0143	CbGpPWpGaD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000121	0.0137	CbGpPWpGaD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000121	0.0137	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000104	0.0118	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PLA2G4F—Crohn's disease	9.32e-05	0.0106	CbGpPWpGaD
Cytarabine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	8.89e-05	0.0101	CbGpPWpGaD
Cytarabine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	8.89e-05	0.0101	CbGpPWpGaD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	8.54e-05	0.00968	CbGpPWpGaD
Cytarabine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	8.29e-05	0.00939	CbGpPWpGaD
Cytarabine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	8.29e-05	0.00939	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—MTMR3—Crohn's disease	7.92e-05	0.00898	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—IL6—Crohn's disease	7.9e-05	0.00894	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.77e-05	0.0088	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.77e-05	0.0088	CbGpPWpGaD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	7.55e-05	0.00855	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—FADS1—Crohn's disease	6.17e-05	0.00699	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.16e-05	0.00698	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.16e-05	0.00698	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GPX4—Crohn's disease	5.78e-05	0.00655	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GCKR—Crohn's disease	5.58e-05	0.00632	CbGpPWpGaD
Cytarabine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	5.54e-05	0.00627	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.47e-05	0.0062	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PLA2G4F—Crohn's disease	5.35e-05	0.00606	CbGpPWpGaD
Cytarabine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	5.16e-05	0.00585	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PLA2G4F—Crohn's disease	4.9e-05	0.00555	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.84e-05	0.00548	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MTMR3—Crohn's disease	4.55e-05	0.00516	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.34e-05	0.00492	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.23e-05	0.00479	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MTMR3—Crohn's disease	4.16e-05	0.00472	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—UBE2D1—Crohn's disease	4.06e-05	0.0046	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	4.04e-05	0.00458	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	4.04e-05	0.00458	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.84e-05	0.00435	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	3.77e-05	0.00427	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	3.77e-05	0.00427	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—FADS1—Crohn's disease	3.55e-05	0.00402	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GPX4—Crohn's disease	3.32e-05	0.00376	CbGpPWpGaD
Cytarabine—CDA—Metabolism—FADS1—Crohn's disease	3.24e-05	0.00367	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GCKR—Crohn's disease	3.21e-05	0.00363	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	3.15e-05	0.00357	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	3.04e-05	0.00344	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PLA2G4F—Crohn's disease	3.04e-05	0.00344	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GPX4—Crohn's disease	3.04e-05	0.00344	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GCKR—Crohn's disease	2.93e-05	0.00332	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—UBE2D1—Crohn's disease	2.9e-05	0.00328	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PLA2G4F—Crohn's disease	2.86e-05	0.00323	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	2.85e-05	0.00322	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—UBE2D1—Crohn's disease	2.81e-05	0.00319	CbGpPWpGaD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.72e-05	0.00308	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—UBE2D1—Crohn's disease	2.72e-05	0.00308	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	2.65e-05	0.00301	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MTMR3—Crohn's disease	2.58e-05	0.00293	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.52e-05	0.00285	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MTMR3—Crohn's disease	2.43e-05	0.00275	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.35e-05	0.00266	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	2.17e-05	0.00245	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.05e-05	0.00233	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.05e-05	0.00233	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—FADS1—Crohn's disease	2.01e-05	0.00228	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—UBE2D1—Crohn's disease	1.94e-05	0.00219	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.91e-05	0.00217	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.91e-05	0.00217	CbGpPWpGaD
Cytarabine—DCK—Metabolism—FADS1—Crohn's disease	1.89e-05	0.00214	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GPX4—Crohn's disease	1.88e-05	0.00213	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.87e-05	0.00212	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GCKR—Crohn's disease	1.82e-05	0.00206	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ALB—Crohn's disease	1.78e-05	0.00201	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GPX4—Crohn's disease	1.77e-05	0.00201	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—ALB—Crohn's disease	1.74e-05	0.00197	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GCKR—Crohn's disease	1.71e-05	0.00194	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—Crohn's disease	1.55e-05	0.00176	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.45e-05	0.00164	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.38e-05	0.00156	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	1.36e-05	0.00154	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.35e-05	0.00153	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.28e-05	0.00145	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.27e-05	0.00143	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.19e-05	0.00135	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	1.13e-05	0.00128	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	1.05e-05	0.00119	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ALB—Crohn's disease	1.02e-05	0.00116	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MTMR3—Crohn's disease	9.62e-06	0.00109	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ALB—Crohn's disease	9.33e-06	0.00106	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	9.06e-06	0.00103	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MTMR3—Crohn's disease	8.96e-06	0.00102	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—Crohn's disease	8.93e-06	0.00101	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.44e-06	0.000956	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—Crohn's disease	8.17e-06	0.000925	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—FADS1—Crohn's disease	7.49e-06	0.000849	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GPX4—Crohn's disease	7.01e-06	0.000795	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—FADS1—Crohn's disease	6.98e-06	0.000791	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GCKR—Crohn's disease	6.77e-06	0.000767	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GPX4—Crohn's disease	6.54e-06	0.000741	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GCKR—Crohn's disease	6.31e-06	0.000715	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ALB—Crohn's disease	5.79e-06	0.000656	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ALB—Crohn's disease	5.44e-06	0.000617	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—Crohn's disease	5.07e-06	0.000574	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—Crohn's disease	4.76e-06	0.00054	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	4.6e-06	0.000521	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.29e-06	0.000486	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	3.81e-06	0.000431	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MTMR3—Crohn's disease	3.24e-06	0.000367	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—FADS1—Crohn's disease	2.52e-06	0.000286	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GPX4—Crohn's disease	2.36e-06	0.000267	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GCKR—Crohn's disease	2.28e-06	0.000258	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ALB—Crohn's disease	2.16e-06	0.000244	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ALB—Crohn's disease	2.01e-06	0.000228	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—Crohn's disease	1.89e-06	0.000214	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—Crohn's disease	1.76e-06	0.000199	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALB—Crohn's disease	7.26e-07	8.22e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—Crohn's disease	6.35e-07	7.19e-05	CbGpPWpGaD
